User profiles for PAVAN S. UPADHYAYULA
Pavan UpadhyayulaVerified email at ucsd.edu Cited by 2435 |
[PDF][PDF] Transferrin receptor is a specific ferroptosis marker
… Murine glioma tissue samples were provided by Pavan S. Upadhyayula and Liang Lei.
This research was supported by grants to BRS from the National Cancer Institute(R35CA209896 …
This research was supported by grants to BRS from the National Cancer Institute(R35CA209896 …
Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers
…, AD Harken, CJ Kinslow, PS Upadhyayula… - ACS chemical …, 2020 - ACS Publications
Although radiation is widely used to treat cancers, resistance mechanisms often develop
and involve activation of DNA repair and inhibition of apoptosis. Therefore, compounds that …
and involve activation of DNA repair and inhibition of apoptosis. Therefore, compounds that …
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma
Only a subset of recurrent glioblastoma (rGBM) responds to anti-PD-1 immunotherapy.
Previously, we reported enrichment of BRAF/PTPN11 mutations in 30% of rGBM that responded …
Previously, we reported enrichment of BRAF/PTPN11 mutations in 30% of rGBM that responded …
[HTML][HTML] Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism
Ferroptosis is mediated by lipid peroxidation of phospholipids containing polyunsaturated
fatty acyl moieties. Glutathione, the key cellular antioxidant capable of inhibiting lipid …
fatty acyl moieties. Glutathione, the key cellular antioxidant capable of inhibiting lipid …
[HTML][HTML] Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker
Background Macrophages are the most common infiltrating immune cells in gliomas and play
a wide variety of pro-tumor and anti-tumor roles. However, the different subpopulations of …
a wide variety of pro-tumor and anti-tumor roles. However, the different subpopulations of …
Update on critical care for acute spinal cord injury in the setting of polytrauma
…, JW Rick, H Deng, CP Partow, PS Upadhyayula… - Neurosurgical …, 2017 - thejns.org
Traumatic spinal cord injury (SCI) often occurs in patients with concurrent traumatic injuries
in other body systems. These patients with polytrauma pose unique challenges to clinicians. …
in other body systems. These patients with polytrauma pose unique challenges to clinicians. …
Association of MGMT promoter methylation with survival in low-grade and anaplastic gliomas after alkylating chemotherapy
Importance O 6 -methylguanine-DNA methyltransferase (MGMT[OMIM156569]) promoter
methylation (mMGMT) is predictive of response to alkylating chemotherapy for glioblastomas …
methylation (mMGMT) is predictive of response to alkylating chemotherapy for glioblastomas …
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial
EF Spinazzi, MG Argenziano, PS Upadhyayula… - The Lancet …, 2022 - thelancet.com
Background Topotecan is cytotoxic to glioma cells but is clinically ineffective because of drug
delivery limitations. Systemic delivery is limited by toxicity and insufficient brain penetrance, …
delivery limitations. Systemic delivery is limited by toxicity and insufficient brain penetrance, …
Focused ultrasound-mediated blood-brain barrier opening increases delivery and efficacy of etoposide for glioblastoma treatment
Purpose Glioblastoma (GBM) is a devastating disease. With the current treatment of surgery
followed by chemoradiation, outcomes remain poor, with median survival of only 15 months …
followed by chemoradiation, outcomes remain poor, with median survival of only 15 months …
[HTML][HTML] Selective serotonin reuptake inhibitors for treating neurocognitive and neuropsychiatric disorders following traumatic brain injury: an evaluation of current …
The prevalence of neuropsychiatric disorders following traumatic brain injury (TBI) is 20%–50%,
and disorders of mood and cognition may remain even after recovery of neurologic …
and disorders of mood and cognition may remain even after recovery of neurologic …